A ground breaking ice pack, which reduces pain and improves joint mobility among osteoarthritis patients and helps athletes recover quicker and more effectively from injury or surgery, has been launched by North Yorkshire healthcare innovations company – Salitas. The revolutionary MORPHO™ Cryo-Matrix remains colder up to 12 times longer than conventional gel packs and is not wet or messy and is easy to prepare and apply. It can be programmed to stay at a constant ‘cold’ temperature (with a skin interface temperature in the ideal (7-12°C zone) for up to four hours, as opposed to the 20 minutes associated with conventional gel packs. It is made from a unique matrix structure that moulds to the patients’ contours, even when they are moving; allowing patients to receive treatment whilst taking part in exercise, training schedules or physiotherapy programmes. These unique features allow joints and muscles to be kept at the right temperature, for the right amount of time, promoting faster recovery rates after surgery or injury.
Ideal for professional sports people who want to get back to full fitness fast, MORPHO™ can also be used as a long term treatment for osteoarthritis patients – one of the most chronic diseases affecting the elderly. A recent study carried out in Belgium concluded that if patients use MORPHO™ regularly it can be more effective than standard pharmacological treatments such as paracetamol to relieve pain and improve joint mobility.
Richard Wilson, Managing Director at Salitas, said: “The MORPHO™ Cryo-Matrix is a fantastic solution and has a number of unique qualities, which sets it aside from other cryotherapy treatments across the globe. It ensures the injured joint or muscle receives the right temperature, for the right length of time, even when moving.
“It can be used by top athletes to aid the rehabilitation of acute sport injuries, ease the effects of arthritis, rheumatism and multiple sclerosis and help millions of patients recover from injuries faster.”
Salitas is a company committed to developing innovations in modern healthcare. The company is currently involved in an extensive research and development programme for a range of products designed to improve treatment and aid recovery.
With its roots as a spin-out company from the University of Bradford, Salitas has attracted significant investment which will allow it to broaden its product offering. Although now operating fully independently, the company continues to work closely with the University to develop new products and in addition, makes a direct contribution from its sales to the University’s Plastic Surgery and Burns Research Unit. The company’s operations are based in Knaresborough, North Yorkshire.
Source: MORPHO™ Cryo-Matrix